Laserfiche WebLink
6. Provide child and family supports for parenting women with OUD and any co- <br />occurring SUDA4H conditions. <br />7. Provide enhanced family support and child care services for parents with OUD and <br />any co-occurring SUD/\4H conditions. <br />8. Provide enhanced support for children and family members suffering trauma as a <br />result of addiction in the family; and offer trauma-informed behavioral health <br />treatment for adverse childhood events. <br />9. Offer home-based wrap-around services to persons with OUD and any co-occurring <br />SUDA4H conditions, including, but not limited to, parent skills training. <br />10. Provide support for Children's Services-Fund additional positions and selices, <br />including supportive housing and other residential services, relating to children being <br />removed from the home andlor placed in foster care due to custodial opioid use. <br />PART TWO: PREVENTION <br />F. PREVENT OVER.PRESCRIBING AND ENST]RE APPROPRIATE <br />PRESCRIBING AND DISPENSING OF OPIOIDS <br />Support efforts to prevent over-prescribing and ensure appropriate prescribing and <br />dispensing of opioids through evidence-based or evidence-informed programs or <br />strategies that may include, but are not limited to, the following: <br />1. Funding medical provider education and outreach regarding best prescribing practices <br />for opioids consistent with the Guidelines for Prescribing Opioids for Chronic Pain <br />from the U.S. Centers for Disease Control and Prevention, including providers at <br />hospitals (academic detailing). <br />2. Training for health care providers regarding safe and responsible opioid prescribing, <br />dosing, and tapering patients off opioids. <br />3. Continuing Medical Education (CME) on appropriate prescribing of opioids. <br />4. Providing Support for non-opioid pain treatment alternatives, including training <br />providers to offer or refer to multi-modal, evidence-informed treatment of pain. <br />5. Supporting enhancements or improvements to Prescription Drug Monitoring <br />Programs (*PDMPs"), including, but not limited to, improvements that: <br />l. Increase the number of prescribers using PDMPs; <br />2. Improve point-of-care decision-making by increasing the quantity, quality, or <br />format of data available to prescribers using PDMPs, by improving the <br />interface that prescribers use to access PDMP data, or both; or <br />J- 10